Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1981 1
1990 2
1991 2
1992 1
1998 1
1999 1
2000 2
2001 1
2002 3
2005 2
2006 2
2009 2
2010 2
2011 5
2012 3
2013 4
2014 6
2015 1
2016 4
2017 4
2018 4
2019 4
2020 3
2021 6
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Composite B-cell and T-cell lymphomas: clinical, pathological, and molecular features of three cases and literature review.
Jin X, Liu H, Li J, Xiao X, Yuan X, Chen P, Chen B, Liang Y, Huang F. Jin X, et al. J Zhejiang Univ Sci B. 2023 Aug 15;24(8):711-722. doi: 10.1631/jzus.B2300181. J Zhejiang Univ Sci B. 2023. PMID: 37551557 Free PMC article. Review.
We found that the occurrence of CL is associated with Epstein-Barr virus infection and DNMT3a, IDH2, and TP53 mutations, and the prognosis of the disease is closely related to the T-cell lymphoma components....
We found that the occurrence of CL is associated with Epstein-Barr virus infection and DNMT3a, IDH2, and TP53 mutations, and the prognosi …
Composite lymphoma.
Kim H, Hendrickson R, Dorfman RF. Kim H, et al. Cancer. 1977 Sep;40(3):959-76. doi: 10.1002/1097-0142(197709)40:3<959::aid-cncr2820400302>3.0.co;2-3. Cancer. 1977. PMID: 332325 No abstract available.
Pathology of lymphoma progression.
Müller-Hermelink HK, Zettl A, Pfeifer W, Ott G. Müller-Hermelink HK, et al. Histopathology. 2001 Apr;38(4):285-306. doi: 10.1046/j.1365-2559.2001.01120.x. Histopathology. 2001. PMID: 11318894 Review.
Reflecting the stepwise process of oncogenesis, lymphomas may cumulatively develop a more aggressive phenotype during the course of disease, a process referred to as lymphoma progression. ...
Reflecting the stepwise process of oncogenesis, lymphomas may cumulatively develop a more aggressive phenotype during the course of d …
Composite Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia and Follicular Lymphoma: A Clinicopathological Study of Six Cases.
Jelloul FZ, Chen QH, Yang T, Haghi N, Brody J, Zhang X, Sheikh-Fayyaz S. Jelloul FZ, et al. Int J Surg Pathol. 2018 Apr;26(2):135-144. doi: 10.1177/1066896917737161. Epub 2017 Oct 26. Int J Surg Pathol. 2018. PMID: 29069998
The CL affects elderly individuals, presents with advanced clinical stage, and appears to have a relatively indolent clinical course....
The CL affects elderly individuals, presents with advanced clinical stage, and appears to have a relatively indolent clinical course. …
Limited stage I and II follicular non-Hodgkin's lymphoma: the Nebraska Lymphoma Study Group experience.
Tezcan H, Vose JM, Bast M, Bierman PJ, Kessinger A, Armitage JO. Tezcan H, et al. Leuk Lymphoma. 1999 Jul;34(3-4):273-85. doi: 10.3109/10428199909050952. Leuk Lymphoma. 1999. PMID: 10439364 Review.
The purpose of this study was to evaluate the outcome and prognostic factors of patients with limited stage follicular non-Hodgkin's lymphoma treated prospectively by the Nebraska Lymphoma Study Group (NLSG). ...
The purpose of this study was to evaluate the outcome and prognostic factors of patients with limited stage follicular non-Hodgkin's …
Clinicopathological features of splenic tumours of lymphoid tissue.
Chen DB, Shen DH, Yang SM, Fang XZ. Chen DB, et al. Pathol Res Pract. 2018 Dec;214(12):1952-1958. doi: 10.1016/j.prp.2018.07.021. Epub 2018 Jul 27. Pathol Res Pract. 2018. PMID: 30087035
The chemotherapy protocol included Hyper-CVAD A/B with/without R (Rituximab), COP, CHOP with/without R etc. The prognosis of those with elevated LDH level, high clinical staging, B symptom, and older than 60 year old was obviously worse, and the prognosis of DLBCL w …
The chemotherapy protocol included Hyper-CVAD A/B with/without R (Rituximab), COP, CHOP with/without R etc. The prognosis of those wi …
Composite lymphoma with relapse of enteropathy-type T-cell lymphoma.
Du Z, Chen J, Zhou X, Zhang T, Chen B, Tang F. Du Z, et al. Leuk Lymphoma. 2009 May;50(5):749-56. doi: 10.1080/10428190902795519. Leuk Lymphoma. 2009. PMID: 19330653 Review.
We review the medical literature on composite B- and T-cell lymphomas and discuss their diagnosis, pathogenesis, prognosis and treatment....
We review the medical literature on composite B- and T-cell lymphomas and discuss their diagnosis, pathogenesis, prognosis and treatm …
60 results